Back

Silent lacunar infarction and risk of cerebrovascular events in patients treated with direct-acting oral anticoagulants

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Stroke risk in interventional and medical cardiac treatment Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Mr Hangkuan Liu

Tianjin Medical University General Hospital, Tianjin (China)

5 More presentations in this session

Presentation thumbnail
Major clinical outcomes in patients with carotid artery stenosis undergoing transcatheter aortic valve replacement: an updated meta-analysis
Doctor T. Theodoropoulou (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Anticoagulation prescription patterns and thromboembolic risk and anticoagulation in trigger-induced atrial fibrillation in critically ill patients a systematic review and meta-analysis
Mr J. Koolwijk (Eindhoven, NL)
Abstract Slides Video
Presentation thumbnail
The sex difference in early cardiac events following acute ischaemic stroke: an individual patient data pooled analysis from the VISTA database
Doctor H. Ishiguchi (Ube, JP)
Abstract Slides
Presentation thumbnail
Low on-treatment diastolic blood pressure, pulse pressure, and mean arterial pressure does not increase risk of stroke: a post-hoc analysis of the ESPRIT trial
Ms L. Lei (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
The impact of patent foramen ovale on left atrial reservoir strain in young patients with cryptogenic ischemic stroke - the SECRETO study
Mr R. Sindre (Bergen, NO)
Abstract Slides Video

Access the full session

Session thumbnail
Stroke risk in interventional and medical cardiac treatment

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Association between warfarin and direct oral anticoagulants users and risk of mortality: cohort studies in England and Hong Kong
thumbnail
Congress Presentation
One-year effectiveness and safety outcomes of edoxaban treatment in Chinese patients with atrial fibrillation: First snapshot of more than 4,800 patients from the ETNA-AF-China study
thumbnail
Congress Presentation
Association between preprocedural thromboembolic or bleeding events under oral anticoagulation therapy and mid-term outcomes after percutaneous left atrial appendage closure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources